Interestingly, we observed a trend towards increased hepatic Ldlr expression in DCA-treated mice, which has previously been suggested54 and in a long-term therapeutic perspective could further help decelerate atherosclerosis progression. The gene discussed is LDLR; the disease is atherosclerosis.